# | Title | Journal | Year | Citations |
---|
1 | CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S | Transplantation | 1974 | 3,345 |
2 | HETEROTOPIC TRANSPLANTS OF BONE MARROW | Transplantation | 1968 | 1,512 |
3 | Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation | Transplantation | 2003 | 1,311 |
4 | MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS | Transplantation | 1995 | 1,288 |
5 | STROMAL CELLS RESPONSIBLE FOR TRANSFERRING THE MICROENVIRONMENT OF THE HEMOPOIETIC TISSUES | Transplantation | 1974 | 1,215 |
6 | PRINCIPLES OF SOLID-ORGAN PRESERVATION BY COLD STORAGE | Transplantation | 1988 | 1,195 |
7 | SEROTYPING FOR HOMOTRANSPLANTATION XVIII. REFINEMENT OF MICRODROPLET LYMPHOCYTE CYTOTOXICITY TEST | Transplantation | 1968 | 1,057 |
8 | A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1 | Transplantation | 1997 | 1,040 |
9 | Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease | Transplantation | 2006 | 1,003 |
10 | RISK FACTORS FOR PRIMARY DYSFUNCTION AFTER LIVER TRANSPLANTATION—A MULTIVARIATE ANALYSIS | Transplantation | 1993 | 937 |
11 | A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1 | Transplantation | 1996 | 933 |
12 | International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation | Transplantation | 2010 | 898 |
13 | DELAYED GRAFT FUNCTION: RISK FACTORS AND IMPLICATIONS FOR RENAL ALLOGRAFT SURVIVAL1 | Transplantation | 1997 | 871 |
14 | IMPACT OF GRAFT SIZE MISMATCHING ON GRAFT PROGNOSIS IN LIVER TRANSPLANTATION FROM LIVING DONORS1,2 | Transplantation | 1999 | 859 |
15 | Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations | Transplantation | 2005 | 842 |
16 | A Comprehensive Risk Quantification Score for Deceased Donor Kidneys: The Kidney Donor Risk Index | Transplantation | 2009 | 825 |
17 | VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION | Transplantation | 1987 | 807 |
18 | SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATION | Transplantation | 1999 | 800 |
19 | The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation | Transplantation | 2018 | 784 |
20 | PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE | Transplantation | 1973 | 765 |
21 | PRESERVATION AND REPERFUSION INJURIES IN LIVER ALLOGRAFTS | Transplantation | 1992 | 762 |
22 | THE ROLE OF ENDOTHELIAL CELLS IN INFLAMMATION | Transplantation | 1990 | 730 |
23 | NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURY | Transplantation | 1993 | 720 |
24 | Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues | Transplantation | 1968 | 720 |
25 | AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINS | Transplantation | 1968 | 719 |
26 | Laparoscopic live donor nephrectomy | Transplantation | 1995 | 707 |
27 | Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors1 | Transplantation | 2002 | 689 |
28 | Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation | Transplantation | 2013 | 679 |
29 | Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes | Transplantation | 2002 | 671 |
30 | MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1 | Transplantation | 1997 | 652 |
31 | Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation | Transplantation | 2013 | 651 |
32 | EVALUATION OF THE TRYPAN BLUE TECHNIQUE FOR DETERMINATION OF CELL VIABILITY | Transplantation | 1964 | 638 |
33 | LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTS | Transplantation | 1993 | 616 |
34 | INCIDENCE OF SKIN CANCER AFTER RENAL TRANSPLANTATION IN THE NETHERLANDS | Transplantation | 1990 | 614 |
35 | GENOTYPIC VARIATION IN THE TRANSFORMING GROWTH FACTOR-??1 GENE | Transplantation | 1998 | 589 |
36 | PORTAL VEIN THROMBOSIS IN ADULTS UNDERGOING LIVER TRANSPLANTATION | Transplantation | 2000 | 580 |
37 | RECOMBINANT-INBRED STRAINS AN AID TO FINDING IDENTITY, LINKAGE, AND FUNCTION OF HISTOCOMPATIBILITY AND OTHER GENES | Transplantation | 1971 | 578 |
38 | Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells | Transplantation | 2003 | 571 |
39 | PRODUCTION OF EMBRYONAL α-GLOBULIN BY TRANSPLANTABLE MOUSE HEPATOMAS | Transplantation | 1963 | 570 |
40 | A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS | Transplantation | 2001 | 570 |
41 | Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo Malignancies | Transplantation | 2005 | 561 |
42 | ORTHOTOPIC LIVER TRANSPLANTATION IN THE RAT | Transplantation | 1979 | 549 |
43 | NEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1 | Transplantation | 2003 | 547 |
44 | PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS | Transplantation | 2000 | 545 |
45 | A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1 | Transplantation | 1998 | 545 |
46 | MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS | Transplantation | 1997 | 541 |
47 | Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial | Transplantation | 2009 | 524 |
48 | Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface | Transplantation | 2004 | 521 |
49 | AN IMPROVED METHOD FOR ISOLATION OF MOUSE PANCREATIC ISLETS | Transplantation | 1985 | 516 |
50 | Mixed Allogeneic Chimerism And Renal Allograft Tolerance In Cynomolgus Monkeys | Transplantation | 1995 | 502 |